Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Recruiting now
Conditions studied: Cardiovascular Diseases, Metabolic Syndrome, Obesity, Prediabetes, Mental Health Disorders, Endocrine Dysfunction, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease (CKD)
In brief
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.
Key facts
- Study ID
- NCT07106879
- Run by
- Clindove Research LLC
- People needed
- 7000
- Starts
- 2025-07-30
- Expected to finish
- 2030-12-01
- Last updated by the study team
- 2025-08-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Any participant of age 18 years and over
- Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures.
You may not qualify if…
- Pregnant or breastfeeding individuals
- Individuals having severe cognitive impairment or inability to provide informed consent
- Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization
- Individuals who are currently participating in another research study that conflicts with pre-screening data collection
- Individuals having known history of drug/alcohol misuse
- Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health.
Where it is running
- Clindove Research LLC — Brooklyn, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.